Manuel Requena Shares The Results of the RESISTANT International Registry
Manuel Requena, Interventional Neurologist at Vall d’Hebron Barcelona Hospital Campus, shared in LinkedIn:
”I am pleased to share the results of the RESISTANT International Registry, recently published in Stroke: Vascular and Interventional Neurology, evaluating intracranial stenting during acute endovascular therapy for ischemic stroke.
I am deeply grateful to all the investigators, interventional teams, and stroke centers worldwide whose collaboration, commitment, and expertise made the RESISTANT registry possible.
This study reflects the power of international collaboration in advancing stroke care.
Together, we collected the largest cohort of patients who underwent acute intracranial stenting (876 patients across 36 international centers).
Key findings:
1. Acute intracranial stenting proved feasible and effective, achieving successful reperfusion (eTICI 2b–3) in nearly 90% of cases.
2. 41% of patients achieved good functional outcomes (mRS 0–2) at 90 days, despite the complexity of these challenging scenarios.
3. Final successful reperfusion and a lower number of thrombectomy attempts before stenting were the strongest predictors of favorable outcomes.
4. Reocclusion occurred in a minority of cases, mostly within the first 48 hours, and no independent predictors of symptomatic intracranial hemorrhage were identified.
Some substudies will be published very soon and we are working on new ones.”
Read the full article here.
Article: Intracranial Stenting During Acute Endovascular Therapy of Stroke: Clinical and Radiological Outcomes of the RESISTANT International Registry
Authors: Manuel Requena, Marta Olivé-Gadea, Francesco Diana, Johannes Kaesmacher, Adnan Mujanovic, Serdar Geyik, Songul Senadim, Alejandro Tomasello
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
-
Sep 11, 2026, 09:35Yasir Khan: Travel Related Blood Clots – What Are the Chances?
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib
-
Sep 11, 2026, 08:00Noor Gajraj: MTHFR Helps Turn Folate, Vitamin B9, Into The Form The Body Uses
-
Sep 11, 2026, 07:59Lisa Lacy: Living With Hereditary Antithrombin Deficiency and the Constant Threat of Clotting
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD